Amazon bans NMN gross sales beginning March 13 2023 – RENUE

Amazon bans NMN gross sales beginning March 13 2023 – RENUE

Amazon has introduced that it will likely be banning the sale of NMN (nicotinamide mononucleotide) from Monday, March 13 2023. This determination follows the U.S. Meals and Drug Administration’s (FDA) response to a New Dietary Ingredient Notification that NMN was first approved for investigation as a brand new drug. Which means NMN is not thought-about a dietary complement, however is now thought-about a drug or drug ingredient, and is thus precluded from use in dietary dietary supplements primarily based on the Dietary Dietary supplements Well being and Training Act (DSHEA).

“Merchandise that comprise NMN as an ingredient can not be offered or distributed as a dietary complement by producers or retailers in the USA,” the e-mail from Amazon Companies said. “If you wish to promote NMN on Amazon, you have to present that you’re authorized by the FDA for over-the-counter gross sales.”

NMN has been offered in a wide range of dietary complement merchandise for a number of years and has been marketed for its anti-aging advantages. It’s unclear how this ban will influence the supply of NMN dietary supplements on different on-line platforms, in addition to in retail shops.


In a letter to distributors promoting NMN, Amazon inspired distributors to evaluation their product listings to make sure compliance. Distributors can be given the chance to take away their NMN listings to be able to keep away from any potential enforcement motion.

This ban comes as a shock to many dietary complement customers, who had been counting on NMN dietary supplements for its purported well being advantages. It’s unclear what the long-term impacts of this ban can be.

This amazon ban was not surprising because the the FDA reclassifying NMN as a drug again in October 2022.

FDA concluded within the fall of 2022 that β-NMN (beta-nicotinamide mononucleotide)—often known as NMN—was excluded from the definition of a dietary complement as a result of being first investigated as a drug.

Just like current motion in opposition to NAC

This isn’t the primary time Amazon has taken motion to take away from its platform a well-liked dietary complement that FDA decided was barred in pure merchandise as a result of being both authorized or investigated as a drug earlier than it was marketed in a complement. Amazon did so with NAC (N-acetyl-L-cysteine), which was later the topic of a lawsuit filed by the Pure Merchandise Affiliation in opposition to FDA in U.S. District Courtroom in Maryland.

In the end, FDA adopted a coverage of “enforcement discretion” to allow the sale of NAC dietary supplements, and Amazon final yr resumed gross sales of the merchandise.


FDA clarification

In accordance with an FDA spokesperson, as soon as the company made the connection between NMN and a drug below investigation known as MIB-626 studied by Metro Worldwide Biotech, it decided the ingredient was excluded as a dietary complement below the Federal Meals, Drug & Beauty Act (FD&C Act).

“When the FDA initially reviewed NDI notifications regarding NMN, NMN was not clearly recognized as an article that was approved for investigation, i.e. MIB-626,” an FDA spokesperson beforehand informed Pure Merchandise Insider. “As soon as the FDA was made conscious of the connection between NMN and MIB-626, we concluded NMN is, actually, excluded from the definition of a dietary complement below part 201(ff)(3)(B)(ii) of the FD&C Act. The explanations for our conclusion are defined within the FDA’s supplemental response letter to NDIN 1259.”

“That is simply yet one more occasion the place the FDA’s interpretation of the legislation will not be solely unsuitable however has precipitated confusion and important financial hurt,” he concluded.

Amazon didn’t instantly reply to a request for remark for this story.

Outlook going ahead

We consider this story will finally find yourself as the sooner skirmish over NAC, and NMN can be returning to Amazon, however it isn’t assured.

It’s potential the FDA will determine to struggle tougher this time and cease all gross sales from each platform.

We’ll proceed to publish updates on the battle  with the FDA right here.

For now, we have now all our NMN and different NAD+ precursors proven beneath in inventory.


$39.95 $23.97 — or subscribe and save 5%

$59.95 — or subscribe and save 5%

$104.95 — or subscribe and save 5%

$68.95 — or subscribe and save 5%

$75.95 — or subscribe and save 5%

$59.95 — or subscribe and save 5%

$59.95 — or subscribe and save 5%

$84.95 — or subscribe and save 5%

$84.95 — or subscribe and save 5%

$84.95 — or subscribe and save 5%



Product Reviews